E-LIB Suche - Ergebnisse für: Kovalszky, I.

1

KIT Mutation Incidence and Pattern of Melanoma in Central E..:

Doma, V. ; Barbai, T. ; Beleaua, M.-A....
Pathology & Oncology Research. 26 (2019) 1 - p. 17-22 , 2019

Link: https://doi.org/10.1007/..

2

Molecular and therapeutic aspects of advanced urachal cance:

Modos, O. ; Keresztes, D. ; Nyirády, P....
European Urology Supplements. 16 (2017) 11 - p. e2840 , 2017

Link: https://doi.org/10.1016/..

3

Characterisation of bioenergetic pathways and related regul..:

Jeney, A. ; Hujber, Z. ; Szoboszlai, N....
Cancer Cell International. 16 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

4

9 Matrix remodeling in head and neck squamous cell carcinom..:

Dudas, J. ; Fullar, A. ; Bitsche, M....
Oral Oncology. 51 (2015) 5 - p. e30 , 2015

Link: https://doi.org/10.1016/..

5

P0321 : Increased anti-tumor effect of vitamin D after CYP2..:

Jozilan, H.N.A. ; Horvath, P. ; Kosa, J.P....
Journal of Hepatology. 62 (2015) - p. S429 , 2015

Link: https://doi.org/10.1016/..

6

Mutation analysis of EGFR signal transduction pathway in ur..:

Modos, O. ; Szarvas, T. ; Reis, H....
European Urology Supplements. 14 (2015) 6 - p. e1215 , 2015

Link: https://doi.org/10.1016/..

7

P226 miRNAS ARE DIFFERENTLY EXPRESSED IN CHRONIC HEPATITIS ..:

Gyöngyösi, B. ; Jármay, K. ; Karácsony, G....
Journal of Hepatology. 60 (2014) 1 - p. S141 , 2014

Link: https://doi.org/10.1016/..

8

280 MICRORNA EXPRESSION SEEMS TO DIMINISH WITH HEPATOCELLUL..:

Gyongyosi, B. ; Gyugos, M. ; Kovalszky, I....
Journal of Hepatology. 56 (2012) - p. S116 , 2012

Link: https://doi.org/10.1016/..

9

796 MIR-122 AND MIR-221 EXPRESSION IN STEATOTIC AND NON-STE..:

Lendvai, G. ; Jármay, K. ; Kiss, A...
Journal of Hepatology. 54 (2011) - p. S319-S320 , 2011

Link: https://doi.org/10.1016/..

10

Microarray Profiling Reveals That Placental Transcriptomes ..:

Várkonyi, T. ; Nagy, B. ; Füle, T....
Placenta. 32 (2011) - p. S21-S29 , 2011

Link: https://doi.org/10.1016/..

11

224 REMARKABLE INCREASE IN CYP24A1 MRNA LEVEL AFTER 1,25-DI..:

Horvath, E. ; Lakatos, P. ; Balla, B....
Journal of Hepatology. 54 (2011) - p. S94 , 2011

Link: https://doi.org/10.1016/..

12

1084 POSTER Claudin-1 Acts as a Tumour Suppressor in Hepato..:

Somorácz, A. ; Tátrai, P. ; Lendvai, G....
European Journal of Cancer. 47 (2011) - p. S120 , 2011

Link: https://doi.org/10.1016/..

13

Leptin‐based glycopeptide induces weight loss and simultane..:

Kovalszky, I. ; Surmacz, E. ; Scolaro, L....
Diabetes, Obesity and Metabolism. 12 (2010) 5 - p. 393-402 , 2010

Link: https://doi.org/10.1111/..

14

Preclinical advantages of intramuscularly administered pept..:

Ostorhazi, E. ; Rozgonyi, F. ; Sztodola, A....
Journal of Antimicrobial Chemotherapy. 65 (2010) 11 - p. 2416-2422 , 2010

Link: https://doi.org/10.1093/..

15

Effect of syndecan‐1 overexpression on mesenchymal tumour c..:

Zong, F. ; Fthenou, E. ; Castro, J....
Cell Proliferation. 43 (2009) 1 - p. 29-40 , 2009

Link: https://doi.org/10.1111/..